Pharmacogenetic considerations in the elderly patient.

Area of Science:

• Geriatric Pharmacology
• Clinical Pharmacogenetics
• Drug Therapy Optimization

Background:

• Elderly patients often exhibit altered drug pharmacokinetics and pharmacodynamics.
• Polypharmacy and age-related physiological changes complicate drug selection and dosing in the elderly.
• Pharmacogenetic variations can significantly influence drug response and toxicity in older individuals.

Purpose of the Study:

• To evaluate the added value of pharmacogenetic data in guiding drug therapy for elderly patients.
• To highlight specific examples of pharmacogenetic influences on medications commonly used in the elderly.
• To underscore the importance of personalized medicine in geriatric pharmacotherapy.

Main Methods:

• Systematic literature search of PubMed and Google Scholar for pharmacogenetics in the elderly.
• Inclusion of studies detailing drug therapy rationale, pharmacogenetic dosing guidelines, and therapeutic principles for older adults.
• Extraction of specific drug examples demonstrating pharmacogenetic impacts on elderly patient populations.

Main Results:

• Pharmacogenetic data provides supplementary information for optimizing drug therapy in the elderly.
• Examples include meperidine, tramadol, amitriptyline, nortriptyline, flecainide, and propafenone, illustrating pharmacogenetic influences.
• Identified drug examples align with Beers criteria and established pharmacogenetic guidelines.

Conclusions:

• Incorporating pharmacogenetic information aids clinicians in making more informed drug therapy decisions for elderly patients.
• Personalized pharmacogenetic approaches can lead to safer and more effective medication management in geriatric care.
• Further integration of pharmacogenetics is recommended for improved clinical outcomes in the elderly.